Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361

Alva A., Csoszi T., ÖZGÜROĞLU M., Matsubara N., Geczi L., Cheng S. Y., ...More

ESMO Virtual Congress, ELECTR NETWORK, 19 September - 18 October 2020, vol.31, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 31
  • Doi Number: 10.1016/j.annonc.2020.08.2252
  • Country: ELECTR NETWORK
  • Istanbul University Affiliated: No